CRISTIANO, Antonio et al. The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID : VEN/AZA effectively targets AML clones. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 14, n. 1, p. e2022041, 2022. DOI: 10.4084/MJHID.2022.041. Disponível em: Acesso em: 3 mar. 2024.